Karolinska Development AB ser. B (KDEV) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.004x

Based on the latest financial reports, Karolinska Development AB ser. B (KDEV) has a cash flow conversion efficiency ratio of -0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-4.18 Million ≈ $-449.51K USD) by net assets (Skr1.10 Billion ≈ $118.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Karolinska Development AB ser. B stock valuation for the company's overall valuation and market capitalisation.

Karolinska Development AB ser. B - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Karolinska Development AB ser. B's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Karolinska Development AB ser. B Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Karolinska Development AB ser. B ranked by their cash flow conversion efficiency. Explore KDEV cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Centric Holdings S.A AT:CENTR	0.008x
Primary Health Properties LSE:PHP	0.035x
Bintai Kinden Corporation Bhd KLSE:6998	-0.075x
Borealis Foods Inc. NASDAQ:BRLS	0.015x
Jeongsan Aikang Co.Ltd KQ:022220	-0.044x
Aligned Genetics Inc KQ:238120	-0.058x
Sung Bo Chem KO:003080	-0.044x
Cobalt Blue Holdings Ltd AU:COB	-0.121x

Annual Cash Flow Conversion Efficiency for Karolinska Development AB ser. B (2008–2025)

The table below shows the annual cash flow conversion efficiency of Karolinska Development AB ser. B from 2008 to 2025. View KDEV stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr1.04 Billion ≈ $112.44 Million	Skr-26.06 Million ≈ $-2.80 Million	-0.025x	-11.01%
2024-12-31	Skr1.24 Billion ≈ $133.31 Million	Skr-27.83 Million ≈ $-2.99 Million	-0.022x	-11.95%
2023-12-31	Skr1.25 Billion ≈ $134.18 Million	Skr-25.02 Million ≈ $-2.69 Million	-0.020x	+23.42%
2022-12-31	Skr1.24 Billion ≈ $133.60 Million	Skr-32.53 Million ≈ $-3.50 Million	-0.026x	-252.38%
2021-12-31	Skr971.09 Million ≈ $104.50 Million	Skr16.70 Million ≈ $1.80 Million	0.017x	+141.46%
2020-12-31	Skr800.27 Million ≈ $86.12 Million	Skr-33.20 Million ≈ $-3.57 Million	-0.041x	-464.27%
2019-12-31	Skr1.01 Billion ≈ $108.45 Million	Skr-7.41 Million ≈ $-797.33K	-0.007x	-116.54%
2018-12-31	Skr296.01 Million ≈ $31.86 Million	Skr13.15 Million ≈ $1.42 Million	0.044x	+4.76%
2017-12-31	Skr267.12 Million ≈ $28.75 Million	Skr11.33 Million ≈ $1.22 Million	0.042x	+114.06%
2016-12-31	Skr29.82 Million ≈ $3.21 Million	Skr-8.99 Million ≈ $-967.90K	-0.302x	+76.99%
2015-12-31	Skr247.88 Million ≈ $26.68 Million	Skr-325.02 Million ≈ $-34.98 Million	-1.311x	-1890.69%
2014-12-31	Skr1.65 Billion ≈ $177.09 Million	Skr-108.39 Million ≈ $-11.66 Million	-0.066x	-50.19%
2013-12-31	Skr1.87 Billion ≈ $201.28 Million	Skr-82.03 Million ≈ $-8.83 Million	-0.044x	+41.84%
2012-12-31	Skr2.02 Billion ≈ $217.84 Million	Skr-152.65 Million ≈ $-16.43 Million	-0.075x	-22.86%
2011-12-31	Skr2.17 Billion ≈ $233.95 Million	Skr-133.44 Million ≈ $-14.36 Million	-0.061x	-8.30%
2010-12-31	Skr1.72 Billion ≈ $184.80 Million	Skr-97.32 Million ≈ $-10.47 Million	-0.057x	-231.51%
2009-12-31	Skr2.00 Billion ≈ $215.05 Million	Skr-34.16 Million ≈ $-3.68 Million	-0.017x	-56.75%
2008-12-31	Skr1.65 Billion ≈ $177.66 Million	Skr-18.00 Million ≈ $-1.94 Million	-0.011x	--

About Karolinska Development AB ser. B

ST:KDEV Sweden Biotechnology

Market Cap

$29.36 Million

Skr272.85 Million SEK

Market Cap Rank

#23953 Global

#454 in Sweden

Share Price

Skr0.29

Change (1 day)

+0.00%

52-Week Range

Skr0.25 - Skr0.91

All Time High

Skr10.82